OBN is the Membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. Our 340-plus Member companies are located across the Golden Triangle and beyond to Nottingham, Manchester and Scotland benefiting from our networking, partnering, purchasing, advising and advocacy activities.
OBN BioTuesday: ‘Improving Valuation Through Better Regulatory Strategy’ – What You Need to Know – LondonTuesday 16th September 2014
At this BioTuesday, kindly hosted by Cell Therapy Catapult, you will first hear presentations from industry experts all of whom have hands on experience of the regulatory, quality and business considerations in successful product development programs. Our speakers will then form a panel to discuss the topic highlighting issues that may arise, discuss how early regulatory input can reduce development times and costs to mitigate risks and demonstrate the impact that poor regulatory planning may have on future collaborative, funding or commercial arrangements.
See you from 6.00pm onwards!